Essure取出手术后的临床结局与患者报告症状:一项系统综述
本系统综述检索PubMed、Embase和Cochrane Library,纳入2014至2024年间18项研究、共2034名女性,评估Essure取出手术的症状改善、生活质量、手术方式及并发症。7项研究报告疼痛、异常子宫出血和乏力显著改善,5项报告生活质量显著改善,总体并发症率为6.5%。结论认为取出手术总体安全,但部分患者症状持续或加重,证据质量受回顾性设计、缺乏对照组及症状测量异质性限制。
要点
- Essure取出术后7项研究报告疼痛、异常子宫出血和乏力显著改善,但部分患者症状持续或加重。
- 5项研究报告生活质量显著改善。
- 总体并发症率为6.5%,其中术中1.2%、术后5.3%。
核心结论
- Essure取出手术总体安全,多数患者报告疼痛减轻、症状改善和生活质量提高,但存在症状持续或加重的情况。
- 证据质量受回顾性病例系列和队列设计、缺乏对照组以及症状和生活质量测量异质且非标准化限制。
研究设计与样本
- 系统综述,检索PubMed、Embase和Cochrane Library,筛选401条记录后纳入2014至2024年间18项研究,共2034名女性,包括病例系列、前瞻性或回顾性队列及1项多中心前瞻性研究,无随机对照试验。
- 采用JBI病例系列关键评价清单评估方法学质量:16项研究为低风险偏倚,1项为中等风险,1项为高风险。
主要发现
- 7项研究报告症状显著改善,包括疼痛减轻、异常子宫出血减少和乏力改善;同时有症状持续或加重的报告。
- 5项研究观察到生活质量显著改善。
- 最常见术式为腹腔镜双侧输卵管切除术并取出装置(52.3%),其次为腹腔镜取出及双侧输卵管切除加宫角切除术(17.5%)和子宫切除术(25.2%),其中子宫切除术中73.4%为腹腔镜。
- 总体并发症率为6.5%,其中术中并发症1.2%,术后并发症5.3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据质量受回顾性病例系列和队列设计限制。
- 缺乏对照组。
- 症状和生活质量测量异质且非标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate clinical outcomes of Essure removal surgery, focusing primarily on symptom reduction and secondarily on indications for removal, quality of life (QoL), surgical technique and complications. DATA SOURCES: PubMed, Embase, and the Cochrane Library were searched. METHODS OF STUDY SELECTION: Studies reporting outcomes of Essure removal were eligible; case reports and articles not in English or Dutch were excluded. Screening of 401 records identified 18 studies between 2014 and 2024, involving 2034 women in case series, prospective or retrospective cohorts, and 1 multicenter prospective study. No randomized controlled trials on this topic exist. Methodologic quality was assessed using the JBI critical appraisal checklist for case series: 16 studies were low, 1 moderate and 1 high risk of bias. TABULATION, INTEGRATION, AND RESULTS: Significant symptom improvement, including pain reduction, reduction in abnormal uterine bleeding, and asthenia, was reported in 7 studies. Persisting or worse symptoms were reported. Significant QoL improvements were observed in 5 studies. The most frequent procedure was laparoscopic bilateral salpingectomy with device (52.3%), followed by laparoscopic removal and bilateral salpingectomy with cornua resection (17.5%) and hysterectomy (25.2%), of which 73.4% were laparoscopic. The overall complication rate was 6.5% (1.2% intraoperative, 5.3% postoperative). CONCLUSION: Essure removal surgery is generally safe, and most patients report reduced pain, improved symptoms, and enhanced QoL. However, persistent or worsening symptoms occur. Evidence quality is limited owing to retrospective case series and cohort designs, absence of control groups, and heterogeneous, nonstandardized symptom and QoL measures.
引用
- Maassen LW, van Gastel DM, van Erp MAJM, et al. Clinical Outcomes and Patient-Reported Symptoms After Essure Removal Surgery: A Systematic Review. J Minim Invasive Gynecol. 2025. PMID: 41110548. doi:10.1016/j.jmig.2025.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。